Eckert & Ziegler Reorganizes its Production Sites
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Real Estate
- Sale of Belgian special purpose property initiated
If the authority approves the transfer as requested, this would result in a release of the disposal reserves previously held for the Belgian production building. This change in the balance sheet would result in a one-off income of 2.7 Mio. EUR for Eckert & Ziegler.
Information and Explanation of the Issuer to this News:
With the merger of the Belgian prostate implant specialist IBt in 2008, Eckert & Ziegler BEBIG SA took over a production site where cyclotrons were used to produce precursors for low-level radioactive implants. Since new production sites are planned in Asia and North America as part of a realignment and globalization of the Pharmaceuticals division, Eckert & Ziegler is now divesting from this special property.
05-March-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Company:||Eckert & Ziegler Strahlen- und Medizintechnik AG|
|Phone:||+49 30 941084-138|
|Fax:||+49 30 941084-112|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||991105|
|End of Announcement||DGAP News Service|